产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
CAS No. |
2666994-25-6 |
|---|---|
中文名称 |
(11aS)-3,7-双(3,5-二氯苯基)-10,11,12,13-四氢-5-羟基-5-氧化物二茚并[7,1-de:1',7'-fg][1,3,2]二氧磷杂环辛烯 |
英文名称 |
(11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin |
别名 |
Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 3,7-bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aS)-;(11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin |
标准英文名 |
1,10-bis(3,5-dichlorophenyl)-12-hydroxy-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide |
分子式 |
C29H19Cl4O4P |
分子量 |
604.25 |
精确分子量 |
601.98 |
SMILES |
O=P1(OC2=C(C3(CC4)C5=C(C(C6=CC(Cl)=CC(Cl)=C6)=CC=C5CC3)O1)C4=CC=C2C7=CC(Cl)=CC(Cl)=C7)O |
标准SMILES |
OP1(=O)OC2=C3C(CCC43CCC3=CC=C(C(O1)=C43)C1=CC(Cl)=CC(Cl)=C1)=CC=C2C1=CC(Cl)=CC(Cl)=C1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
CSYNMLYRUQUBRH-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|